Who Owns NRC Health Company?

NRC Health Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

Who Really Owns NRC Health?

Understanding the ownership structure of NRC Health SWOT Analysis is key to grasping its strategic direction and future potential. From its humble beginnings to its current standing, NRC Health's journey has been marked by significant shifts in ownership. This exploration will uncover the key players who have shaped the company's trajectory, influencing its position within the healthcare industry and its value for investors.

Who Owns NRC Health Company?

The transition of NRC Health company to a publicly traded entity has broadened its ownership base, introducing new dynamics and accountability to shareholders. This shift has also brought increased scrutiny and opportunities for growth, influencing the company's strategic decisions and financial performance. Analyzing the evolution of NRC Health ownership, including the influence of major NRC Health investors and the role of public shareholders, provides valuable insights into its current market position and future prospects. Furthermore, understanding who owns NRC Health is crucial for anyone looking to assess its long-term viability and investment potential, considering factors like the NRC Health stock price and the company's overall financial health.

Who Founded NRC Health?

The foundation of NRC Health rests on its inception in 1981, spearheaded by Michael D. Hays. He served as the company's Chief Executive Officer and President for over four decades, establishing a strong leadership presence from the outset.

Prior to founding NRC Health, Hays gained experience as Vice President and Director of SRI Research Center, Inc., now known as the Gallup Organization. This background likely provided him with insights into market research and healthcare trends, which were crucial for the company's early focus.

While specific details about the initial equity distribution among founders or early investors are not publicly available, Hays's long tenure and transition to Chairman of the Board in June 2025, highlight his enduring influence on the company's strategic direction and ownership structure.

Icon

Early Focus and Leadership

The early mission of NRC Health centered on fulfilling the evolving information requirements of the healthcare sector. This was achieved through internal product development, as the company aimed to provide valuable insights to its clients. The company's commitment to meeting the healthcare industry's information needs is a key aspect of its history.

  • Michael D. Hays founded NRC Health in 1981.
  • Hays served as CEO and President for more than 40 years.
  • The company's early focus was on internal product development to meet the healthcare industry's information needs.
  • Hays transitioned to Chairman of the Board in June 2025.

NRC Health SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

How Has NRC Health’s Ownership Changed Over Time?

NRC Health, previously known as National Research Corporation, is a publicly traded company. It began trading on Nasdaq in 1996. Understanding the evolution of its ownership structure is key to grasping its financial journey and strategic direction.

The company's ownership structure has evolved since its initial public offering. Key events, such as acquisitions or significant shifts in major shareholders, have influenced its trajectory. Analyzing SEC filings, including 10-K annual reports and proxy statements, provides detailed insights into these changes and the impact they've had over time. For example, the company's market capitalization as of June 11, 2025, was approximately $366 million, with roughly 22.8 million shares outstanding. This data is crucial for understanding the current ownership landscape.

Event Year Impact on Ownership
Initial Public Offering (IPO) 1996 Transitioned from private to public ownership, allowing broader investor participation.
Institutional Investment Growth Ongoing Increased holdings by institutional investors like Vanguard and BlackRock, potentially influencing strategic decisions.
Share Repurchases (if any) Variable Can reduce the number of outstanding shares, increasing the ownership stake of existing shareholders.

As of June 2025, the major shareholders of NRC Health include institutional investors such as Vanguard Fiduciary Trust Co., The Vanguard Group, Inc., BlackRock, Inc., and State Street Global Advisors, Inc. Although specific percentages from recent SEC filings for 2024-2025 were not immediately available at the time of writing, these institutions collectively hold a significant portion of the company's stock. This concentration of ownership often indicates a focus on long-term value and can significantly influence strategic decisions through their voting power. Further insights can be found by reviewing the Marketing Strategy of NRC Health.

Icon

Key Takeaways on NRC Health Ownership

NRC Health is a publicly traded company with a history of institutional investment. Understanding the major shareholders and their influence is crucial.

  • Institutional investors hold a significant portion of the company's shares.
  • The company's market capitalization was $366 million as of June 11, 2025.
  • SEC filings provide detailed information on ownership changes.
  • The evolution of ownership impacts the company's strategic direction.

NRC Health PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

Who Sits on NRC Health’s Board?

The Board of Directors at NRC Health, a pivotal aspect of NRC Health ownership, guides the company's strategic direction and safeguards shareholder interests. Mike Hays, the founder, assumed the role of Chairman of the Board on June 1, 2025, after transitioning from CEO, maintaining a key leadership position. The board's composition and operation are governed by the company's bylaws, which stipulate a staggered three-year term structure for directors, divided into three classes. Shareholders elect these directors, with each share of common stock typically carrying one vote. This structure is essential for understanding the dynamics of NRC Health company governance.

As of March 20, 2024, the company had 23,871,543 shares of Common Stock outstanding and eligible to vote, which is important for understanding NRC Health investors influence. Historically, the company has utilized a dual-class share structure, with Class A and Class B common stock, each offering different voting rights. Specifically, each share of Class A common stock was entitled to one-one hundredth (1/100th) of one vote, while each share of Class B common stock was entitled to one vote. This structure, if still in place, could give select shareholders, such as founders or early investors, disproportionate voting power. For more information, you can read Brief History of NRC Health.

Board Member Title Affiliation
Mike Hays Chairman of the Board N/A
(Information available in the 2024 Annual Report/2025 Proxy Statement) (Information available in the 2024 Annual Report/2025 Proxy Statement) (Information available in the 2024 Annual Report/2025 Proxy Statement)
(Information available in the 2024 Annual Report/2025 Proxy Statement) (Information available in the 2024 Annual Report/2025 Proxy Statement) (Information available in the 2024 Annual Report/2025 Proxy Statement)
Icon

Understanding NRC Health's Governance

The Board of Directors at NRC Health plays a critical role in the company's governance. The board oversees strategic decisions and represents shareholder interests. The company's bylaws are essential for understanding the voting rights and the structure of the board.

  • The Chairman of the Board is Mike Hays.
  • Shareholders elect directors.
  • Each share of common stock generally has one vote.
  • The 2024 Annual Report/2025 Proxy Statement provides detailed information.

NRC Health Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

What Recent Changes Have Shaped NRC Health’s Ownership Landscape?

In recent developments, NRC Health announced a significant leadership transition. Trent Green will become the incoming Chief Executive Officer on June 1, 2025. This change sees Michael Hays, the company's founder and long-serving CEO, move into the role of Chairman of the Board, ensuring a smooth continuation of the company's mission. This shift is a key indicator of the company's strategic direction and future planning.

Expanding its leadership team, NRC Health appointed four executive officers in February 2024: Helen Hrdy as Chief Customer Officer, Jason Hahn as Chief Revenue Officer, Christophe Louvion as Chief Product Technology Officer, and Andy Monnich as Chief Corporate Development Officer. Furthermore, in April 2025, the company announced a new share repurchase program, signaling confidence in its financial health. Financial results from the first quarter of 2025 showed an increase in total recurring contract value and an acceleration of the sales force expansion.

Metric Value Year
Revenue Approximately $35 million 2024 (Q2)
Earnings per Diluted Share $0.26 2024 (Q2)
Net Indebtedness Approximately $42 million June 30, 2024
Total Recurring Contract Value Approximately $138 million June 30, 2024

On July 15, 2024, NRC Health completed the acquisition of Nobl Health for approximately $6 million in cash, with a potential earnout of up to $1 million. At the time of acquisition, Nobl Health had approximately $2 million in total recurring contract value. This acquisition is part of NRC Health's strategy to enhance its offerings, particularly in patient rounding insights and workflow applications. These strategic moves demonstrate NRC Health's commitment to growth and innovation within the healthcare industry.

Icon Leadership Changes

The appointment of Trent Green as CEO and Michael Hays' transition to Chairman of the Board highlights a strategic leadership shift. This change aims to ensure continuity and drive future growth. The expanded executive team further supports the company's strategic initiatives and market expansion.

Icon Financial Performance

The company's financial performance in Q2 2024 showed revenues of approximately $35 million, with earnings per diluted share at $0.26. A new share repurchase program was announced in April 2025, indicating financial confidence. The total recurring contract value reached approximately $138 million by June 30, 2024.

Icon Acquisition Strategy

The acquisition of Nobl Health for approximately $6 million, with a potential earnout, is a key strategic move. This acquisition enhances NRC Health's offerings in patient rounding insights. Nobl Health had about $2 million in total recurring contract value at the time of acquisition.

Icon Market Position and Outlook

NRC Health's strategic moves, including leadership changes and acquisitions, are designed to strengthen its market position. The company is focusing on innovation and growth within the healthcare sector. The financial results and strategic initiatives reflect a positive outlook for the company.

NRC Health Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Related Blogs

Data Sources

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.